Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 376

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 376
---
centive Plan, (ii) cancelation of any option or SAR previously granted under the Equity Incentive Plan in exchange for another option or SAR with a lower purchase price or base price or (iii) cancelation of any option or SAR previously granted under the Equity Incentive Plan in exchange for cash or another award. Eligibility Participants in the Equity Incentive Plan will consist of such officers, other employees, non -employeedirectors, consultants, independent contractors, and agents of New Profusa and its subsidiaries (and such persons who are expected to become any of the foregoing) as selected by the Plan Committee. The aggregate value of cash compensation and the grant date fair value of shares of common stock that may be awarded or granted during any fiscal year of New Profusa to any non -employeedirector will not exceed $500,000 (or, $750,000, with respect to the fiscal year of a non -employeedirector’s initial service as a non -employeedirector); provided, however, that this limit shall not apply to distributions of previously deferred compensation under a deferred compensation plan maintained by New Profusa or compensation received by the director in his or her capacity as an executive officer or employee of New Profusa. It is anticipated that, as of the closing of the Business Combination, approximately 18 employees and non -employeedirectors will be eligible to participate in the Equity Incentive Plan if selected by the Plan Committee to participate. Stock Options and SARs The Equity Incentive Plan provides for the grant of stock options and SARs. The Plan Committee will determine the conditions to the exercisability of each option and SAR. Each option will be exercisable for no more than 10 years after its date of grant. If the option is an incentive stock option and the optionee owns greater than 10% of the voting power of all shares of capital stock of New Profusa (a “ten percent holder”), then the option will be exercisable for no more than five (5) years after its date of grant. Except in the case of substitute awards granted in connection with a corporate transaction, the exercise price of an option will not be less than 100% of the fair market value of a share of New Profusa Common Stock on the date of grant, unless the option is an incentive stock option and the optionee is a 10% holder, in which case the exercise price will not be less than the price required by the Code (currently 100% of fair market value